Apple 01:15
2022 outlook for small/microcaps 03:55
What the new #omicron lockdowns mean for investors. 05:55
Equals 14:00
AstraZeneca 20:25
Boohoo 22:05
Possible options to convert of Amryt Pharma shares into Nasdaq ADS’s (5:1 ratio) 23:20
Oncimmune 28:05
Getech, pivoting towards ‘Green Hydrogen’ 31:25 (NEW POSITON)
Two ‘potential’ fallen angles for 2022 40:35
a) Purplebricks 41:15 (NEW POSITON) & ULS Technology 52:15
b) Venture Life 52:10
The information, investment views and recommendations in this article are provided for general information purposes only. Nothing in this article should be construed as a solicitation to buy or sell any financial product relating to any companies under discussion or to engage in or refrain from doing so or engaging in any other transaction. Any opinions or comments are made to the best of the knowledge and belief of the writer but no responsibility is accepted for actions based on such opinions or comments. Vox Markets may receive payment from companies mentioned for enhanced profiling or publication presence. The writer may or may not hold investments in the companies under discussion.
